r We constructed a comprehensive mathematical model of the spontaneous electrical activity of a human sinoatrial node (SAN) pacemaker cell, starting from the recent Severi-DiFrancesco model of rabbit SAN cells.
Introduction
There is no need to explain the important role of the sinoatrial node (SAN) in cardiac function. Many studies have focused on this small but crucial piece of cardiac tissue and provided detailed knowledge of the physiological processes governing its function. Yet we still have an incomplete understanding of the cellular basis of the pacemaker activity of the SAN and, specifically, the degree of contribution of the different mechanisms involved is still debated (Lakatta & DiFrancesco, 2009; DiFrancesco, 2010; Lakatta, 2010; Noble et al. 2010; Verkerk & Wilders, 2010; Himeno et al. 2011; DiFrancesco & Noble, 2012; Lakatta & Maltsev, 2012; Rosen et al. 2012; Monfredi et al. 2013; Yaniv et al. 2013 Yaniv et al. , 2015 .
To date, almost all experiments on SAN electrophysiology have been carried out on animals, particularly rabbits. These experiments have shed light on several aspects, such as characteristics of membrane currents, effects of ion channel blockers, calcium handling and beating rate modulation. This considerable amount of data has allowed the development of increasingly comprehensive and detailed action potential (AP) models (Wilders, 2007) subsequent to the first mathematical models reproducing pacemaker activity being created (McAllister et al. 1975; Yanagihara et al. 1980; Noble & Noble, 1984; DiFrancesco & Noble, 1985) . Recently, novel SAN AP models have been proposed, incorporating detailed calcium-handling dynamics and providing in-depth descriptions of the underlying events at the cellular level in guinea-pig, mouse and rabbit (Himeno et al. 2008; Maltsev & Lakatta, 2009; Kharche et al. 2011; Severi et al. 2012) .
However, the translation of animal data/models to humans is not straightforward (probably even less so for SAN pacemaker cells than working myocardial cells), given the big difference in their main 'output' (i.e. pacing rate) between human and laboratory animals.
Very few measurements are available for human SAN cells because failing explanted hearts, as obtained during heart transplantation, usually do not contain the SAN region, which remains inside the receiver's chest. Drouin (1997) was the first to record human adult APs from SAN tissue, obtained from four subjects affected by left ventricle infarction. Ten years later, Verkerk et al. (2007b) investigated the electrophysiological properties of three isolated SAN cells from a woman who underwent SAN excision because of a paroxysmal non-treatable tachycardia. They recorded APs and characterized the funny current using whole-cell patch clamp in current clamp and voltage clamp mode. In a subsequent study (Verkerk et al. 2013) , the same group reported further data from the same patient, regarding the calcium transient (CaT) measured by indo-1 fluorescent dye.
Some proof-of-concept attempts have been made to model spontaneous activity in human cardiac pacemaker cells. Seemann et al. (2006) presented the first human SAN AP model as part of a wider 3D model of human atria. Their model started from the model of Courtemanche et al. (1998) of the human atrial AP and achieved automaticity by including rabbit SAN currents (e.g. I f , I CaT , etc.), formulated in accordance with Zhang et al. (2000) . Unfortunately, no reliable experimental comparisons could be made with the model of Seemann et al. (2006) . Chandler et al. (2009) described the 'molecular architecture' of adult human SAN tissue obtained from healthy hearts, comparing it to the non-specialized tissue of the right atrium. They developed a SAN model, again starting from the model of Courtemanche et al. (1998) ; by scaling the maximal conductances based on mRNA data, they provided a proof of concept that automaticity can be the result of the specific gene expression pattern of human SAN tissue. However, some mechanisms were not included, and no quantitative AP features were computed or compared with the human data available at that time. Accordingly, as Chandler et al. (2009) themselves affirmed, 'the resulting model cannot be considered definitive and is a guide only' .
Recently, Verkerk and Wilders (2015) computationally investigated mutations affecting hyperpolarizationactivated cyclic nucleotide-gated cation channel 4 (HCN4) channels, but they ' . . . preferred to study I f in simulated action potential clamp experiments, thus ensuring that the action potential followed the course of that of a human SAN pacemaker cell' because a human SAN AP model was not formulated yet. Thus, they highlighted the need for such a model. Much more recent is the human SAN AP model formulated by Pohl et al. (2016) . In their model, to investigate the cardiac neuromodulation (as exerted by vagal stimulation) that aims to reduce heart rate, they focused their attention on the effects that ACh has on the rate. Starting from the rabbit SAN model reported by Dokos et al. (1996) , they updated current formulations, integrating data from human SAN cells (Verkerk et al. 2007b) and human ion channels expressed in heterologous systems Xenopus oocytes, etc.) . The simulated cycle length (CL) was in accordance with the experimental recordings of human SAN cell APs by Verkerk et al. (2007b) but, unfortunately, the AP morphology, both during the diastolic depolarization (DD) phase and AP, was very unlike that obtained experimentally.
The main aim of the present study is the formulation of a human SAN AP model strictly based on and constrained by the available electrophysiological data. We started from the recent rabbit SAN model by Severi et al. (2012) , which integrates the two principal mechanisms that determine the beating rate: the 'membrane clock' and 'calcium clock' (Maltsev & Lakatta, 2009; Lakatta et al. 2010) . Several current formulations were updated based on available measurements. A set of parameters, for which no specific data were available, were tuned to reproduce the measured AP and calcium transient data. We then used the model to assess the effects of several mutations affecting heart rate and investigated the rate modulation in some relevant conditions.
Methods

Model development
The starting point of our work was the rabbit SAN cell model by Severi et al. (2012) . Several currents, pumps and exchangers were reviewed, based on electrophysiological data from human SAN cells (Verkerk et al. 2007b) , self-beating embryonic human cardiomyocytes (Danielsson et al. 2013) , as selected for their automaticity, and data on gene expression patterns in SAN vs. atrial human cells (Chandler et al. 2009) . Specifically, the model was constrained by: AP parameters obtained from three isolated human SAN pacemaker cells by Verkerk et al. (2007b) ; the voltage clamp data on I f in the same three cells (Verkerk et al. 2007b) ; the effect of 2 mM Cs + , as an I f blocker, on the AP of a single isolated human SAN pacemaker cell (Verkerk et al. 2007b) ; and the Ca 2+ transient data of a single isolated human SAN pacemaker cell (Verkerk et al. 2013) . For a small set of parameters for which no specific experimental data were available, values were obtained via an automatic optimization procedure (see below). Figure 1 shows a schematic diagram of the human SAN AP model. The compartmentalization, essential for the calcium handling description, is inherited from the parent model, as were the sarcolemmal ionic currents, pumps and exchangers. The ultrarapid delayed rectifier K + current (I Kur ) was developed independently. Table 1 reports the changes with respect to the rabbit SAN model and the rationale for each. All model equations and parameter values are provided in Appendix 1.
Automatic optimization procedure
An automatic optimization was performed to tune the parameters for which human experimental data were not available to fit the recorded AP and cytosolic calcium transient traces (Verkerk et al. 2007b (Verkerk et al. , 2013 .
The cost function of the optimization procedure was based on quantitative data on AP features [action potential amplitude (APA), maximum diastolic potential (MDP), CL, maximum rate of rise of membrane potential [(dV/dt) + , a funny current blocker, on CL (Verkerk et al. 2007b (Verkerk et al. , 2013 . The most critical features (CL, MDP and CL prolongation in response to Cs + ) were weighted more heavily.
After each simulation, the set of quantitative descriptors was extracted and compared with the experimental data. The cell is divided into three compartments: subsarcolemma, cytosol and sarcoplasmic reticulum (SR), which is subdivided into junctional and network SR. Ca 2+ handling is described by: two diffusion fluxes (J diff from the subsarcolemmal space to the cytosol and J tr from the network SR to the junctional SR), the Ca 2+ uptake from the cytosol into the network SR by the SERCA pump (J up ) and the Ca 2+ release (J rel ) from the junctional SR into the subsarcolemmal space by the RyRs. Sodium, calcium and potassium ions pass the sarcolemmal membrane through 11 different ionic channels, pumps and exchangers, as indicated. (Verkerk et al. 2007b) C m , membrane capacitance; L cell , R cell , length and radius of the cell; g i , maximal conductance for the i type channel; I NaK,max = maximal activity of Na + /K + pump; P CaT , P CaL , permeability for the T-and L-type calcium currents; V ½,dL , k dL , half-activation potential and slope factor for voltage-dependent dL gate; K NaCa , maximal current of NCX; k s , Ca 2+ diffusion rate for RyR channels; k om , RyR deactivation rate; kf CM , kf CQ , association constants for calmodulin and calsequestrin. The reported features in parentheses (APD, CL, Ca i range, DD, OS) are those that were most impacted during the automatic optimization procedure.
If a particular observed feature fell out of the experimental mean ± SEM range, the contribution of this feature to the overall cost was increased in a linear way; otherwise, no handicap was added. The search for the optimal solution was conducted using the Nelder-Mead simplex method (Lagarias et al. 1998) . The obtained parameters are shown in Table 1 . Further details on the optimization procedure are reported in Appendix 2.
Cell capacitance and dimensions
We assumed a membrane capacitance (C m ) of 57 pF, and a cylindrical cell shape with a length of 67 μm and a diameter of 7.8 μm, in accordance with the experimental data of Verkerk et al. (2007b) , who reported values of 56.6 ± 8.7 pF, 66.7 ± 6.3 μm and 7.8 ± 0.4 μm (mean ± SEM, n = 4), respectively. The dimensions of the intracellular compartments, expressed as a percentage of cell volume, were adopted from the parent model.
Membrane currents
Here, we specify each of the sarcolemmal currents flowing through the ionic channels, pumps and exchangers shown in Fig. 1 , except for I K,ACh , which is described in the section 'Autonomic modulation' . All membrane currents were scaled up by the new value of the cell capacitance, aiming to maintain the conductance densities adopted from the parent model. Changes to the conductance densities, as a result of parameter tuning, are reported in the corresponding current subsections.
Funny current (I f ).
From their experiments on human SAN cells, Verkerk et al. (2007b) reported a maximal I f conductance of 75.2 ± 3.8 pS/pF (mean ± SEM, n = 3). Consequently, we assumed a maximal I f conductance (g f ) of 4.3 nS, given our C m of 57 pF. The funny current was implemented by splitting it into Na + and K + components, with a g fNa g fK conductance ratio of 0.5927, thus arriving at an I f reversal potential (E f ) of -22 mV, in accordance with the experimentally determined value of -22.1 ± 2.4 mV (mean ± SEM, n = 3) (Verkerk et al. 2007b) . A first-order Hodgkin and Huxley-type kinetic scheme was assumed for I f activation, as described by the formulations presented by Verkerk et al. (2007a) and Verkerk and Wilders (2010) . The activation time constant τ y was formulated in accordance with Verkerk et al. (2007a) , who used a Dokos et al. (1996) -type equation to fit the experimental data obtained from three human adult SAN cells by Verkerk et al. (2007b) .
Rapid delayed rectifier K
+ current (I Kr ). The steady-state activation curve of I Kr (pa gate) was fitted to data from embryonic human cardiomyocytes by Danielsson et al. (2013) . The measured tail current density following activation pulses from −70 to +50 mV was normalized with respect to the maximal measured value and then fitted with a Boltzmann equation. The conductance g Kr was set to 4.2 nS (+10% compared to parent model) to hyperpolarize the maximum diastolic potential (MDP) and obtain the value experimentally observed in human SAN (Drouin, 1997; Verkerk et al. 2007b ).
Slow delayed rectifier K
+ current (I Ks ). The steady-state activation curve for I Ks (n gate) was updated in accordance with the experimental data of Danielsson et al. (2013) . The reported current density vs. voltage data were normalized to the maximal measured value and subjected to square-root, in line with the second-order Hodgkin and Huxley-type kinetic scheme. Data were then fitted with a Boltzmann equation. The conductance g Ks was set to 0.65 nS (11.4 pS/pF), −78% with respect to the parent model, as a result of the automatic optimization procedure. On one hand, Chandler et al. (2009) reported an mRNA expression level in the human SAN equal to 69% of that in non-specialized atrium cells. On the other hand, very discordant values have been reported for g Ks in human atrial cells up to now, ranging from 3.5 pS/pF (Grandi et al. 2011) to 20 pS/pF (Nygren et al. 1998) , whereas g Ks was adjusted to 129 pS/pF in the model of Courtemanche et al. (1998) simply to match AP duration.
Ultrarapid delayed rectifier K
+ current (I Kur ). Chandler et al. (2009) reported the expression of K V 1.5 channels, responsible for I Kur , in human SAN tissue. Because I Kur was not present in the parent model, we added this current, formulating it as in the human atrial cell model of Maleckar et al. (2009) . The g Kur conductance was set to 0.1539 nS, 6% of the corresponding atrial value, based on the automatic optimization procedure.
Transient outward K
+ current (I to ). We maintained the parent model formulation, which, in turn, was adopted from the model of Maltsev & Lakatta (2009) . The conductance g to was set to 3.5 nS, slightly reduced (−1.5%) compared to the rabbit SAN model. Sodium/potassium pump current (I NaK ). The formulation by Severi et al. (2012) , which was in turn derived from that of Kurata et al. (2002) , was adopted. The maximal activity of the Na + /K + pump was reduced by 28% (I NaK,max = 0.08105 nA) through automatic optimization.
Sodium current (I Na ). The presence of fast Na + current (I Na ) in human SAN cells has been reported by Verkerk et al. (2009b) . The steady-state activation and inactivation curves (gates m and h) of the parent model have been simply rewritten in a sigmoidal formulation (see Appendix 1) to facilitate the implementation of mutations related to Na v 1.5 channels.
T-type Ca
2+ current (I CaT ). The mathematical formulation of I CaT was inherited from the parent model and thus based on the constant field equation by Sarai et al. (2003) . The Ca 2+ permeability P CaT was set to 0.04132 nA mM −1 (+15%), as obtained by automatic optimization.
L-type Ca
2+ current (I CaL ). Changes in I CaL kinetics were limited to the voltage-dependent steady-state activation curve dL Ý . The half-maximal activation voltage (V ½,dL ) was slightly shifted towards less negative potentials (from −20.3 to −16.45 mV) and the slope factor k dL was slightly increased (from 4.2 to 4.337 mV). The Ca 2+ permeability was increased by 28% (P CaL = 0.4578 nA mM −1 ). All of these parameters were updated using automatic optimization.
Sodium/calcium exchange current (I NaCa ). The set of equations describing the Na + /Ca 2+ exchanger activity was adopted from the parent model and thus originally derived by Kurata et al. (2002) . The maximal current provided by the exchanger was set to 3.343 nA, reduced by 53% as a result of the automatic optimization procedure.
Calcium handling
As in the parent model, the mathematical formulation of Ca 2+ handling was based on Maltsev and Lakatta (2009) 
Ion concentrations
Ca
2+ dynamics for the four compartments were described by the mass balance equations. Intracellular Na + was fixed at 5 mM, the Na + concentration in the pipette solution used in the whole cell configuration by Verkerk et al. (2007b) . In such a configuration, intracellular Na + is expected to equilibrate with the pipette solution.
Sensitivity analysis
The sensitivity analysis was performed according to the approach proposed by Sobie (2009) . The randomization procedure involved the parameters that underwent automatic optimization and the remaining maximal conductances, for a total of 18 parameters. The conductances were randomized through scaling factors chosen from a log-normal distribution with a median value of one and an SD σ = 0.1873; thus, an increase of 20% represents 1 SD away from the control value.
Shifts of the steady-state gating variables and the sarco-endoplasmic reticulum Ca 2+ -ATPase (SERCA) pump calcium dependence were extracted from a normal distribution centered on zero, with SDs of σ = 2 mV and σ = 50 nM, respectively. The randomization was run for a population of 500 models. All of them were simulated and the corresponding AP and CaT features were computed.
Parameters and their corresponding features were collected in the X (n × p) and Y (p × m) matrices, respectively, where n corresponds to the number of simulations showing an auto-oscillating behaviour (< 500), p is the number of parameters and m is the number of computed features. Next, the matrix B (p × m) containing the sensitivity coefficients was computed using the formula:
Functional effects of mutations
Mutations in genes encoding (subunits of) ion channels may lead to changes in electrophysiological properties. We incorporated such functional effects into the model by modifying the parameters of the affected ion channel according to values reported in the literature (Tables 2-4) .
Only studies reporting changes in heart rate as (one of) the clinical effects of mutations were included. The altered functionality was implemented as a shift of the steady-state (de)activation or inactivation curve, a change in its slope factor or a reduction in maximal conductance. Mutations may also cause a change in the voltage-dependent time constant (τ) curve. When changes in the time constant had been experimentally reported, they were implemented by a constant multiplication factor. Otherwise, τ underwent the same voltage shift applied to steady-state (in)activation curve.
When I Na channels are incompletely inactivated, an additional non-inactivating term is added to the control formulation of I Na , to reproduce a persistent, 'late' inward sodium current (I Na,L ), which is not normally present in the model. Its maximal conductance was derived from the ratio I Na,L :I Na peak, as observed experimentally.
Autonomic modulation
The effects of 10 nM ACh on I f activation (-7.5 mV shift in voltage dependence of activation), I CaL (3.1% reduction of maximal conductance) and SR Ca 2+ uptake (7% decrease of maximum activity) were all adopted from the parent model (Severi et al. 2012) . The administration of ACh also activates I K,ACh, which is zero in the default model. The I K,ACh formulation was derived from the parent model. The maximal conductance g K,ACh was set to 3.45 nS (reduced by 77.5%) to achieve an overall reduction of the spontaneous rate by 20.8% upon administration of 10 nM ACh, as observed by Bucchi et al. (2007) in rabbit SAN cells.
The targets of isoprenaline (Iso) are I f , I CaL , I NaK , maximal Ca 2+ uptake and I Ks . Changes in currents were adopted from the parent model, except for the modulation of I CaL , where the effect of Iso induced a slightly smaller decrease of the slope factor k dL (−27% with respect to control conditions, instead of the −31% assumed by the parent model). The I CaL current was modulated to fit the experimental data reported by Bucchi et al. (2007) on rabbit SAN cells (26.3 ± 5.4%; mean ± SEM, n = 7) for the same Iso concentration.
Hardware and software
The human SAN model was built in Simulink (The Mathworks, Inc., Natick, MA, USA). Simulations ran on an OS X Mavericks (version 10.9.5) Apple computer (Apple, Cupertino, CA, USA) equipped with an Intel i7 dual core processor (Intel, Santa Clara, CA, USA). Numerical integration was performed by ode15s, a variable order solver based on numerical differentiation formulas, provided by MatLab (The Mathworks, Inc.). Simulations were run until steady-state was reached, which 
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Heterozygous HEK −4.9 NS −4.9 -NC: 73.2 ± 1.6 C: 52.2 ± 1.4 Milanesi et al. (2006) Experimental data are changes relative to wild-type currents. These changes are used to simulate the effect of HCN4 mutations. Oocytes, Xenopus oocytes; HEK, HEK-293 cells; CHO, CHO cells; COS, COS-7 cells. V 1/2 shift, shift in I f steady-state activation curve; slope, slope factor of steady-state activation curve; tau shift, shift in voltage dependence of time constant of activation. -, not reported. NS, no significant change. Heart rate is resting heart rate in index patient (IP), mutation carriers (C), or non-affected family members (non-carriers, NC). occurred after 50 s, based on the observation of calcium concentrations in each compartment. The automatic optimization and feature extraction were performed by custom code in MatLab 2013a. Model code is available at: http://www.mcbeng.it/en/downloads/software/hap-san. html and will also be published in the CellML Model Repository (http://models.cellml.org/).
Results
Human SAN model behaviour in basal conditions
Simulated AP and calcium transient. The simulated AP waveform reproduces the available experimental traces well ( Fig. 2A) . Indeed, most of the quantitative parameters that describe AP morphology (i.e. CL, MDP, APD 90 and DDR 100 ) are within the mean ± SD range of the experimental ones (Verkerk et al. 2007b) (Table 5 ). In particular, the AP generated by the model is characterized by a CL of 814 ms, corresponding to a beating rate of 74 beats min -1 . However, the model presents a higher (dV/dt) max and overshoot (OS) and a longer APD 20 (predicted features beyond the experimental mean ± SD range).
The simulated Ca 2+ transient qualitatively reproduces the single experimental trace acquired by Verkerk et al. (2013) , showing a smaller transient amplitude and longer duration compared to rabbit data. Even if the model predicts slightly lower values for both diastolic and systolic [Ca 2+ ] i , the CaT amplitude (intracellular CaT amplitude; TA) is close to the experimental data ( Fig. 2B and Table 6 ).
The time courses of the underlying currents, Ca 
Experimental data are changes relative to wild-type currents. These changes are used to simulate the effect of SCN5A mutations. Most experimental data are in the presence of the SCN5A channel β-subunit. HEK, HEK-293 cells; COS, COS-7 cells; tsA201, tsA201 cells; Oocytes, Xenopus oocytes. V 1/2 shift, shift in I Na steady-state (in)activation curve; slope, slope factor of steady-state (in)activation curve; tau shift, shift in voltage dependence of time constant of activation; tau, time constant of inactivation; I Na Late, persistent sodium current as percent of peak current under voltage clamp conditions. -, not reported. NS, no significant change. Heart rate is resting heart rate in index patient (IP), mutation carriers (C) or non-affected family members (non-carriers, NC). * Absolute minimum heart rate.
#
Sinus node dysfunction (SND) observed in 16/41 mutation carriers. * * Parameters employed for simulations were selected from two different experimental studies (Bezzina et al. 1999; Veldkamp et al. 2000) . In particular, the set of parameters reported by Veldkamp et al. (2000) was extended with a depolarizing shift of the activation and a remarkable current density reduction as observed by Bezzina et al. (1999) . 
Experimental data are changes relative to wild-type currents. These changes are used to simulate the effect of KCNQ1 mutations. All experimental data are in the presence of the KCNE1 β-subunit. Oocytes, Xenopus oocytes; HEK, HEK-293 cells. -, not reported. Heart rate is resting heart rate in index patient (IP), mutation carriers (C) or non-affected family members (non-carriers, NC). * The ratio between the current density of I Ks in wild-type condition and with R231C mutation (I KsR231C /I KsWT ) used to simulate the voltage-dependent gain of function was estimated from Henrion et al. (2012) .
(depolarizing) and outward (repolarizing) membrane currents are I CaL and I Kr , respectively ( Fig. 3C ). However, the peak amplitude of I tot ( Fig. 3B) , and therefore the maximum AP upstroke velocity, is determined not only by I CaL , but also by I NaCa (Fig. 3E ). Other currents are much smaller in amplitude than I CaL and I Kr . Yet, several are important determinants of the net ionic current during DD, and thus of CL (see below). Of note, as set out below, sinus node dysfunction can result from mutations in I f , I Na and I Ks , which are among the smallest currents (Fig. 3D ).
The calcium-induced calcium release from the jSR upon calcium entry through the I CaL channels is reflected by the rapid increase in J rel ( Fig. 3G ) and the accompanying rapid drop in Ca jSR (Fig. 3K ). The resulting increase in Ca sub ( Fig. 3I ) and Ca i ( Fig. 3J ) generates an increase in Ca 2+ uptake (J up ) (Fig. 3H ).
Ionic currents during the DD phase. Figure 4 shows the time course of individual currents that play a relevant role during DD. The main inward currents during DD are I CaT , I f , I NaCa and I CaL . I CaT activates before the membrane potential reaches MDP and reaches its maximal current density in the first 100 ms of DD (early DD), thus contributing to DDR 100 , and then slowly decreases. I f is considerably smaller than I NaCa but its amplitude during DD is comparable with that of the net inward current ( Verkerk et al. (2009a) and Verkerk and Wilders (2010) . B, simulated (black thick line) and experimentally recorded (grey line) Ca 2+ transient. Experimental data from Verkerk et al. (2013) .
J Physiol 595.7 Comparison between experimental (mean ± SD; n = 3) (Verkerk et al. 2007b ) and simulation data. it provides its maximal contribution in the first half of diastole. I NaCa is a high-density inward current; it slowly diminishes during diastole, whereas it rapidly increases at the end of DD, providing an important contribution to the AP upstroke. A small amount of fast I Na window current is active during DD. It is smaller than I f , yet it is not negligible; it is able to modulate beating rate, as demonstrated by our simulations of mutations in the sodium voltage-gated channel α subunit 5 (SCN5A) gene (see below). I CaL follows a progressive increase during DD and becomes the major contributor to the net inward current at the end of DD; it has a relevant role during both DD and AP. I NaK , I Kr and I Ks are the main outward currents. I NaK slowly increases during DD and reaches its maximal current density during AP, contributing to repolarization. I Kr is the major driver in the repolarization process. It contributes to DD through its progressive decrease during this phase. The contribution of I Ks to DD is almost negligible under control conditions, although gain-of function mutations can lead to a remarkable slowdown of pacemaking (see below).
Sensitivity analysis
Among the randomly generated population of 500 models, more than 300 showed an auto-oscillating behaviour. The results of the sensitivity analysis are reported in Fig. 5A , which shows the coefficients of the sensitivity matrix B, coded in a colour map. Each value in the matrix shows how a change in the parameter P displayed at the top is capable of affecting the feature F displayed on the left, and the coefficients <−0.2 and >0.2 are reported in the corresponding pixel. The obtained map highlights that nine out of the starting 18 parameters show coefficients lower or higher than the selected thresholds of −0.2 and 0.2, respectively.
As illustrated in Fig. 5A , changes in the permeability of I CaL (P CaL ) and its activation kinetics (slope factor k dL and shift in half-activation voltage shift dL ) have a large impact on upstroke velocity (dV/dt), AP duration (APD 20, 50, 90 ) and calcium transient. Furthermore, the kinetics of the I CaL activation gate dL strongly affect CL and DDR 100 . Similarly, a change of the maximal conductance of I Kr (g Kr ) has a high impact on APA, MDP and APD, whereas the maximal activity of NCX (K NaCa ) strongly influences APA, dV/dt and calcium transient. Finally, a shift in the working point of the SERCA pump (shift up ) clearly affects the diastolic calcium concentration (Ca i,min ).
Figure 5B shows that CL is largely determined by the I CaL activation kinetics (through its parameters k dL and shift dL ). Figure 5C shows that DDR 100 is also largely determined by the activation kinetics of I CaL but in the opposite way. In addition, it reveals that the permeability of I CaT (P CaT ) is also an important determinant of DDR 100 .
The parameter randomization, the first step of the linear regression approach, allowed us to explore a neighbourhood, in the parameter space, of the parameter set obtained as a result of the automatic optimization procedure. Only a few parameter sets (out of 500 tested) led to comparable values of the cost function. In particular, only four led to values of MDP, CL, APD 90 and DDR 100 within the target range (i.e. mean ± SEM of experimental values) and only one parameter set led to a slightly lower value of the cost function than the one obtained from the 'optimized' set of parameters. To compare these two models, the effects on the pacemaking rate of mutations affecting I f and I Na were compared for the two parameter sets (as detailed in the section 'Model validation through the simulation of ion channel mutations' below). The 'alternative' set of parameters produced effects in close agreement with the 'optimized' set: the difference in mutation-induced changes in the pacemaking rate was always lower than 2.7%.
The presence of multiple parameter sets compatible with experimental ranges allowed us to compute estimation intervals for the parameters that underwent the optimization procedure (Sarkar & Sobie 2010) . Nominal values and ranges for the optimized parameters are reported in Table A1 in Appendix 2. G and H) , and calcium concentrations (I-K) in control steady-state conditions. Not shown is I K,ACh , which is zero under control conditions. Note differences in ordinate scale.
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To confirm that parameter values outside the estimated confidence interval lead to non-physiological (or at least non-basal) conditions, we tested the effect of changing P CaT by 50% more or 50% less with respect to the parent rabbit model (instead of +15% as in the 'optimized' model). In accordance with the above observation that P CaT is an important determinant of DDR 100 , a large increase in P CaT led to a notably higher beating rate (+17%; from 74 to 86 beats min -1 ), whereas a large decrease in permeability resulted in a slower beating rate (−18%; from 74 to 60 beats min -1 ). These results indicate that I CaT could play a substantial role in pacemaking and underscore that the proposed value for P CaT is quite well constrained (see also Table A1 in Appendix 2).
Model validation through the simulation of ion channel mutations
The implementation of the functional changes in ion channels as a result of genetic mutations allowed validation of the present model of the human SAN AP. A prerequisite of the validation process was that mutations included in the analysis had to be characterized both clinically and electrophysiologically. Specifically, the criteria that a mutation had to satisfy were: (i) the availability of clinical data on adult patients affected by sinus node dysfunction related to the ion channel mutation of interest and (ii) the availability of an electrophysiological characterization of the mutation, usually carried out in heterologous cell systems (COS-7, CHO, tsA201 and HEK-293 cells; Xenopus oocytes), into which the mutation was transfected. Furthermore, to represent the clinical conditions as faithfully as possible, the electrophysiological data were ideally obtained from systems in which the expression of the mutation was heterozygous. However, in the absence of data on heterozygously expressed gain-of-function mutations in potassium voltage-gated channel subfamily Q member 1 (KCNQ1), data from homozygously expressed mutations were used.
We used the data from electrophysiological studies to simulate the effects of mutations in the HCN4, SCN5A and KCNQ1 genes, encoding the HCN4, Na V 1.5 and K V 7.1 pore-forming α-subunits of the I f , I Na and I Ks channels, respectively. Next, we compared the results of our simulations with the clinical data. When clinical data relative to non-carrier family members were available, the model was tuned through autonomic modulation to reproduce the average heart rate reported for non-carriers as the control beating rate. Furthermore, if the clinical control rate was lower than the intrinsic beating rate of the model (74 beats min -1 ), a not-null basal level of ACh was simulated, whereas a fixed percentage of the effects of isoprenaline on all its targets was simulated to obtain higher control rates. When clinical data relative to non-carriers were not available, the effects of mutations were evaluated starting from the intrinsic beating rate of the model. Effects of I f mutations. All the initially observed mutations in HCN4 resulted in a loss of function of I f (Verkerk & Wilders, 2015) , although, recently, a gain-of-function mutation in HCN4 (R524Q) has also been reported by Baruscotti et al. (2017) . A complete list of the mutations taken into consideration in the present study, together with a short description of their electrophysiological characterization and the parameter values used in simulations, is reported in Table 2 .
A loss-of-function-induced decrease in the intensity of I f could be the result of (i) a hyperpolarizing shift of the steady-state activation curve y Ý and time constant τ y [e.g. for the Y481H and G482R (Milano et al. 2014) and the K530N (Duhme et al. 2013 ) mutations]; (ii) a reduction of the maximal conductance [e.g. for the G482R mutation (Schweizer et al. 2014 ) and the D553N mutation (Ueda et al. 2004) ]; and (iii) both of the aforementioned changes together (e.g. for the G480R, A485V and S672R mutations; Verkerk & Wilders, 2015) . Furthermore, there can be mutation-induced changes in the activation and/or deactivation rate of the I f channel that contribute to the decrease of I f intensity (e.g. the slowed activation in case of the G480R mutation; Nof et al. 2007 ).
In the simulations, all three types of loss-of-function mutations led to an increase in CL and thus a reduction of pacemaking rate (Fig. 6A) . A more detailed look at the AP features reveals that DDR 100 showed a substantial decrease for all loss-of-function mutations, varying from 8.5% for the relatively mild S672R mutation (pacemaking rate of 69 beats min -1 ) to 40.7% for the A485V mutation (pacemaking rate of 61 beats min -1 ), whereas APD 90 was almost unchanged in our simulations. Similarly, changes in MDP and APA were almost negligible: the maximum hyperpolarization of the MDP amounted to 0.5 mV and the maximum increase in APA was 0.9 mV (both for the A485V mutation). The only gain-of-function mutation, R524Q, led to an increase in I f by shifting the steady-state activation curve and the time constant curve towards less negative potentials (Baruscotti et al. 2017) . The simulation of the mutation showed a faster pacemaking rate (79 beats min -1 ). DDR 100 had an increase of 8.2%, whereas MDP, APD 90 and APA were unchanged.
The comparison between the pacemaking rates in our simulation data and the clinically observed heart rates ( Fig. 6A) highlighted the ability of the model to reproduce the effects of the mutations on HCN4 channels, at least qualitatively. Quantitatively, the effects in the simulation data are consistently smaller than those observed clinically, which might be expected (see Discussion).
Effects of I Na mutations. A large number of mutations identified in SCN5A are related to sinus dysfunction, such as sinus bradycardia and sinus pauses (often associated with the LQT3 phenotype) and sick sinus syndrome (Veldkamp et al. 2003; Lei et al. 2007) .
A loss of function of the I Na channel can have several causes: (i) a rapid inactivation of the ion channel; (ii) a depolarizing shift of activation; (iii) a hyperpolarizing shift of inactivation; and (iv) a reduction of the current density, which, in some cases, can lead to the non-function phenotype (i.e. a full loss of function). In several cases, multiple causes can be present at the same time, enhancing the reduction of I Na (Table 3) .
The simulations of the effects of loss-of-function I Na mutations showed a decrease in pacemaking rate, up to 11.8% for the E161K mutation. DDR 100 showed a decrease for all mutations (with a maximum of 9.0% for E161K). APD 90 , MDP and APA were almost unchanged for all mutations.
In simulations of KPQ (Nagatomo et al. 1998 ) and E1784K [parameters from Deschênes et al. (2000) or Makita et al. (2008) ] and 1795insD mutations [parameters from Bezzina et al. (1999) and Veldkamp et al. (2000) ], an incomplete inactivation (gain of function) was combined with a loss of function; the absence of a complete inactivation induced a sustained (late) Na + current. The DDR 100 resulting from this combined gain and loss of function showed a decrease (−5.8% for KPQ, −7.9% and −7.7% for E1784K, and −8.0% for 1795insD mutation). By contrast, APD 90 showed an increase for all three mutations (+1.3% for KPQ, +2.2% and +1.5% for E1784K, and +0.6% for 1795insD mutation). The overall effect was a reduction of the pacemaking rate for all simulated mutations (by −4.8% for KPQ, −2.9% and −3.7% for E1784K, and −6.2% for 1795insD mutation). To assess the contribution of an incomplete inactivation of I Na channels in these 'mixed mutations' , we investigated the effect of I NaL alone by introducing this current into a cell in control conditions. The presence of I NaL caused two opposing effects: enhanced inward current during late DD resulted in a steeper DDR, whereas inward I Na current during AP prolonged APD. In our model for g NaL set to 1% of g Na in the control condition, the higher inward current during late DD prevailed. The overall effect of I NaL was a minor increase of the pacemaking rate (+3.2%). However, in the four mixed mutations analysed, the loss-of-function effect prevailed and led to an overall slowdown of the pacemaking rate.
A comparison of pacemaking rates predicted by the model and clinical data is shown in Fig. 6B . The simulation data for the G1406R, D1790G and 1795insD mutations were in close agreement with the clinical data. By contrast, for the other three mutations, the simulations showed a decrease of the beating rate compatible with the loss-of-function behaviour of the mutations, although it was less close to the clinically observed effect.
Effects of I Ks mutations. Both loss-of-function and gain-of-function mutations in KCNQ1, encoding the K V 7.1 pore-forming α-subunit of the I Ks channel, have been reported in relation to sinus bradycardia.
A gain of function of K V 7.1 channels could be the result of (i) a higher current density, as observed for the R231C mutation (Henrion et al. 2012) or (ii) a hyperpolarizing shift of the steady-state activation curve, as observed for the V241F mutation (Ki et al. 2013) . With either mutation, DDR 100 was markedly increased. However, the overall DDR was reduced, leading to a longer DD phase duration. Both mutations showed a slight depolarization of MDP (to −57.6 and −57.1 mV for R231C and V241F, respectively), whereas APD 90 was considerably reduced (by 10.8% and 19.8% for R231C and V241F, respectively). Thus, opposing effects were present. However, the prolongation of the DD phase far outweighed the effects of a higher DDR 100 and a shorter APD 90 , leading to slower pacemaking rates (57 and 40 beats min -1 for R231C and V241F, respectively), which were in good agreement with clinical data (Fig. 6B) .
On the other hand, a loss of function of K V 7.1 channels can be attributed to (i) a lower channel expression or (ii) a depolarizing shift of the steady-state activation curve. The F339 mutation shows both effects (Table 4) (Thomas et al. 2005) . The model predicted a negligible change in pacemaking rate (from 63 to 63.5 beats min -1 ), which is consistent with clinical data (Fig. 6B) ; DDR 100 was slightly reduced (by 2.4%) and APD 90 was increased (by 1.3%), whereas MDP was almost unchanged.
Model-based analysis: effects of I f and Ca 2+ handling modulation on pacemaking Contribution of I f to pacemaking. To quantitatively assess the sensitivity of CL, and thus of pacing rate, to the funny current, we carried out two simulation experiments: (i) a progressive block of funny current, by reducing the maximal conductance g f and (ii) a shift in voltage dependence of the steady-state activation curve, with a range from −15 to +15 mV. Four levels of block were assessed: 30%, 70%, 90% and 100% (i.e. full block) (Fig. 7A) . The total block of funny current led to an increase in CL of 28.1% to 1043 ms, and thus a decrease in pacemaking rate of 22% to 58 beats min -1 , in good accordance with the 26% increase in CL that was experimentally observed by Verkerk et al. (2007b) , who administered 2 mM Cs + as a blocker of I f to a single isolated SAN cell (Fig. 7B) . At this concentration, Cs + almost completely blocks I f in the pacemaker range of potentials, whereas the delayed rectifier K + current, which is also sensitive to Cs + , is only affected slightly (Denyer & Brown, 1990; Zaza et al. 1997; Liu et al. 1998) .
The increase in CL was mainly the result of a lower DDR and longer DD phase (with DDR 100 decreasing by 39.7% to 29 mV s −1 upon full block), whereas APD 90 and MDP remained almost unchanged (Fig. 7A) . Of note, the increase in CL was also largely the result of a lower DDR and longer DD phase in the experiment of Verkerk et al. (2007b) (Fig. 7B) .
Negative shifts of the activation led to an increase in CL, up to 957 ms (+17.5% with respect to control) with a −15 mV shift, whereas positive shifts shortened CL, up to 577 ms (−29.2%) with a +15 mV shift (Fig. 8A) . As with the I f block, DDR 100 was the main descriptive parameter that changed (to 37.7 mV s −1 (−25.8%) with a −15 mV shift and to 75.4 mV s −1 (+56.8%) with a +15 mV shift; Fig. 8B ), whereas APD 90 and MDP remained almost unaffected, as for the I f block (Fig. 8C and D) .
Contribution of I NaCa to pacemaking and spontaneous calcium oscillations. The Na + /Ca 2+ exchanger is an important actor in the generation of the AP and also contributes to the diastolic depolarization phase. To assess the impact that I NaCa has on CL, we performed a progressive reduction of the maximal activity of Na + /Ca 2+ (K NaCa ) (Fig. 9) . Reductions in K NaCa of 50% and 75% unexpectedly led to faster pacemaking, with a rate of 83 beats min -1 J Physiol 595.7 (+12.2%) and 93 beats min -1 (+25.7%), respectively. DDR 100 , APD 90 and MDP contributed synergistically towards a shorter CL: DDR 100 increased remarkably, APD 90 shortened and MDP depolarized (Fig. 9A) . DDR 100 was steeper as a result of a more intense I NaCa density during DD (Fig. 9B and D) because of a higher concentration of [Ca 2+ ] i in the cell (Fig. 9C) . The reduced maximal activity of the Na + /Ca 2+ exchanger also resulted in a lower contribution of I NaCa to the AP: the overshoot potential was lower and repolarization was faster, resulting in a shorter APD.
Higher levels of block of the exchanger (reduction of maximal activity by 90%) stopped the automaticity of the cell. The inward current provided by the Na + /Ca 2+ exchanger was no longer sufficient to make the cell reach its threshold potential for an AP. Membrane potential stabilized at a level approaching -40 mV ( Fig. 9A and B), whereas [Ca 2+ ] i stabilized at a constant value close to 200 nM (Fig. 9C) .
The presence in the model of the 'isolated Ca 2+ oscillator' was also tested, by reproducing the simulations in which all membrane currents are set to zero. Spontaneous oscillations of intracellular and subsarcolemmal calcium were indeed achieved upon a large increase in the SERCA pump activity. Notably, the frequency of these oscillations was definitely higher than the physiological human heart rate (> 5 Hz). In particular, calcium oscillations were not sustained for P up values up to more than 90 nM s −1 ; sustained oscillations, with a frequency of 5 Hz, arose upon increasing P up to a value approaching 100 nM s −1 . This frequency stayed almost constant as P up was increased to 120 mM s −1 , suggesting that it might be not easy to tune the oscillation rate in a robust way, at least in this lumped-parameter model of calcium handling.
Autonomic modulation of pacemaking
The simulated administration of 10 nM ACh resulted in a reduction of spontaneous rate by 20.8%. DDR 100 was decreased by 9.8% and APD 90 was shortened from 161.5 to 154 ms (−4.6%); MDP was not altered. Even though ACh had opposing effects on DDR 100 and APD 90 , the increase in CL showed that the DDR 100 reduction prevailed (Fig. 10A) .
We also assessed the contribution of each individual ion current by applying the ACh effect to each current separately. Changes in I K,ACh and I f were dominant, inducing a reduction in the pacemaking rate of 11.6% and 6.9%, respectively. Exposure of only I CaL to ACh resulted in a minor effect (1.1% reduction of pacemaking rate), whereas the modification of J up led to negligible changes. Simulating the ACh effects on all targets but one led to similar results: I K,ACh and I f played a primary role, as demonstrated by the model-predicted reduction of the pacemaking rate by 8% and 13% (when I K,ACh and I f were the only unchanged currents), respectively.
The overall effect induced by 1 μM Iso resulted in an increase in the pacemaking rate of 27.9% to 94 beats min -1 (Fig. 10A) . DDR 100 increased from 48.1 mV s −1 in control conditions to 53.4 mV s −1 with Iso, whereas APD 90 and MDP were almost unchanged. The assessment of the effect of Iso through each of the Iso-sensitive currents alone showed that the modified I f and I CaL both led to a substantial increase in pacemaking rate (14.2% and 16.4%, respectively). The increased activity of I NaK , on the other hand, slowed the pacemaking rate (−13.1%), whereas Iso-induced changes in I Ks and J up only had a small effect (+1.5% and −0.4%, respectively).
Considering the effects of all currents but one confirmed the above results; when all the currents but one, either I CaL , I f , I NaK , I Ks or J up , were affected by 1 μM Iso, an increase in beating rate equal to 2.1%, 9.6%, 40.6%, 21.3% and 28.7%, respectively, was observed. Of note, these values also show that I Ks becomes more prominent at higher rates, when there is less time for its deactivation. The effect of I Ks alone is small, with a 1.5% increase in beating rate, although the 'all but one' data (21.3% increase) reveal a more prominent role of I Ks at higher rates; indeed, the net contribution of I Ks (overall effect -all but I Ks effect) shows an increase of beating rate equal to 6.6% (27.9-21.3%).
The model was capable of reproducing the full clinical range of human heart rate, assumed to be from 40 to 180 beats min -1 . In particular, the model predicted that a concentration of ACh equal to 25 nM was able to slow down the pacemaking rate to 40 beats min -1 (−45.9%). This concentration was responsible for a negative shift of the (de)activation steady-state curve y Ý and time constant τ y of −6.3 mV, a reduction of P CaL equal to −6.7% and a maximal activity of SERCA pump P up reduced to 85% with respect to control conditions. The I K,ACh was also affected, showing a peak value of 0.33 pA/pF. The model also showed stable oscillations at a pacing frequency equal to 182 beats min -1 . Changes in the Iso target parameters responsible for this pacemaking rate were quantified (with respect to control conditions) as: y Ý and τ y were shifted by +12 mV; I NaK,max and g Ks were increased by 92%; and n Ý and τ n were shifted by −22 mV. I CaL was affected by a 96.8% increase of P CaL , a shift of dL Ý and τ dL by -12.8 mV, and a slope factor k dL reduced by −29.7%. Thus, we directly tuned the parameters affected by Iso, increasing the aforementioned effects of 1 μM Iso to arrive at a pacemaking rate approaching 180 beats min -1 .
Discussion
In the present study, we formulated a comprehensive human SAN AP model, starting from a state-of-the-art model of rabbit cardiac pacemaker cells, and converting it into a species-specific description using human experimental data as far as possible. A novel aspect is the adoption of an automatic optimization procedure, tightly bounded by the AP features, to identify the parameters for which experimental data are presently unavailable.
Previously, Chandler et al. (2009) showed that scaling ion current densities, according to the gene expression pattern they found in human SAN vs. atrial tissue, gives rise to automaticity in the human atrial cell model of Courtemanche et al. (1998) . However, the values of the descriptive parameters of AP, in particular MDP, APA and APD, were far from the experimentally observed ones.
Our model is able to reproduce the main experimentally observed electrophysiological features (AP waveform, calcium transient) and the simulated changes in pacemaking rate as a result of mutations affecting ionic channels are in line with clinical data. Furthermore, it allows the investigation of relevant conditions such as I f block, NCX block and autonomic stimulation, as we have demonstrated above.
Construction of the model
AP models of cardiac cells are commonly based on voltage clamp data for ionic current identification and current clamp data for model validation. We tried to maximally exploit the scarce data available on human SAN cells, aiming at a detailed reproduction of experimental AP morphology. Updating the description of the funny current, based on the experimental data obtained by Verkerk et al. (2007b) , was also crucial. In our human cell model, I f current density during DD is considerably lower than in rabbit SAN cells, although it remains comparable to the net inward current as reported by Verkerk and Wilders (2010) in their virtual AP clamp experiments. In control conditions, the model reproduces the experimental AP features well. The simulated AP is characterized by CL = 814 ms, which is close to the experimentally observed values (Verkerk et al. 2007b) and critical parameters such as MDP, APD 90 and DDR 100 are all within the range of the experimental data ( Table 5) . As a consequence, the model shows a representative behaviour during both DD (subthreshold) and AP (Fig. 3) .
To achieve a calcium transient close to the experimental trace, several actors of Ca 2+ handling underwent changes; in particular, maximal NCX activity was reduced by 53%, and a sigmoidal equation was introduced to describe SR uptake. These updates allowed a higher diastolic [Ca 2+ ] i and finer control during DD.
The Cs + -induced CL prolongation that was experimentally observed was also taken into account to tune parameters. Simulating the administration of 2 mM Cs + led to an increase in CL of 28.1%, close to the experimentally observed 26% (Fig. 7) . This Cs + concentration was reported to selectively and almost fully block the funny current (Verkerk et al. 2007b ) and so the reported prolongation established the maximal extent of the contribution of I f to the pacemaking rate decrease in our model. Thus, the experimentally observed levels of I f block by Cs + were highly relevant. Accordingly, we should not forget that a voltage-dependent partial block of funny channels by 5 mM Cs + has been reported elsewhere (DiFrancesco et al. 1986) . If the parameters in our model were tuned to reproduce a similar partial Cs + -induced block, a larger effect of complete I f block would be observed in simulations.
Sensitivity analysis
The sensitivity analysis highlighted the strong impact of I CaL , in particular its activation kinetics (gate dL), on CL and on the calcium transient. A slight increase/decrease of the slope factor k dL and a shift of the working point of the steady-state curve of the activation gate are able to substantially change these two features; indeed, the availability of open I CaL channels during the highly sensitive DD phase is strongly affected by slight changes of the dL kinetics.
The same AP can be produced by multiple sets of parameters. However, the observation that only a few parameter sets, out of a total of 500, produced simulation data within the experimental range suggests that the parameters should fall within a narrow range. Ranges in Table A1 in Appendix 2 are a first attempt to determine such physiological intervals for human SAN cells exploiting the limited experimental data. Future measurements will help to refine the information extracted by our investigation.
The illustrative investigation on the effects of changes in P CaT suggests that this parameter is well constrained, and also that I CaT plays a role in pacemaking, which is consistent with the report by Mangoni et al. (2006) who studied mice with a disrupted gene coding for Ca V 3.1 channels, as responsible for T-type calcium current.
Ion channel mutations
Having obtained satisfying behaviour in control conditions, we further validated the model through the implementation of mutations affecting ion channels. Because of the clinical importance of this research, a large number of studies have previously been carried out and a considerable amount of both clinical and electrophysiological data are available. HCN4 is the most abundant isoform of the HCN family. Most HCN4 mutations result in a loss of function of I f , although, recently, Baruscotti et al. (2017) found a mutation that results in a gain of function. In our simulations, I f exerted its contribution during DD, influencing the amount of net inward current, and thus the slope of this phase. In this way, a loss of function of I f leads to a slower rate, whereas a gain of function leads to a faster one. A remarkable aspect of this finding is that I f is able to modulate DDR at the same time as leaving other important parameters (such as APD and MDP) unchanged.
The simulations of loss-of-function mutations in HCN4 show a considerable slowing but not a complete cessation of pacemaker activity. The slowing is consistently smaller than that observed in the associated mutation carriers (Fig. 6) . The difference between clinical and simulated effects of mutations, however, is to be expected because the hyperpolarizing effect of the surrounding atrium will result in a more prominent role of I f in the SA node of the intact heart. Of note, our current model appears to be more promising for assessing the effects of HCN4 mutations in humans than the comprehensive rabbit SAN cell models described by Maltsev and Lakatta (2009) and Severi et al. (2012) . As recently reported by Wilders and Verkerk (2016) , the mutation effects appear to be highly underestimated in the Maltsev-Lakatta model, in which a slowing of only 5.2% was observed for the most severe of the 11 mutations tested (A485V; 21.4% in the present model) and highly overestimated in the Severi-DiFrancesco model, where pacemaker activity ceased for five of the 11 mutations, including A485V.
In the validation stage, a large number of mutations in the SCN5A-encoded Na v 1.5 channels were assessed. We observed two kinds of mutations: the first kind J Physiol 595.7 was characterized by changes in electrophysiological properties that led to a loss of function of channels (E161K, G1406R and D1790G); the second kind showed the concurrent presence of loss of function and gain of function ( KPQ, E1784K and 1795insD). The latter effect was the result of an incomplete inactivation of I Na channels, which was incorporated into the model by means of the I Na,L current.
Loss-of-function mutations reduced the inward current carried by I Na and therefore decreased DDR. Thus, I Na regulated heart rate in a way analogous to that of the funny current; however, the lower weight of I Na in the overall inward current resulted in quantitatively fewer extensive effects with respect to I f .
Similar to the mutations in HCN4, the slowing in pacemaking rate associated with mutations in SCN5A is consistently smaller in simulations than in the intact heart (Fig. 6) . Again, this is to be expected because the hyperpolarizing effect of the surrounding atrium will also result in a more prominent role of I Na in the SA node of the intact heart. In our current model, we observed a decrease in the pacemaking rate of up to 14.9% for the most severe SCN5A mutation. We could not test the SCN5A mutation effects in the Maltsev-Lakatta rabbit SAN cell model because this model lacks I Na . In the Severi-DiFrancesco rabbit SAN cell model, the decrease in pacemaking rate was almost negligible for each of the SCN5A mutations tested, with a maximum near 1%.
The simulated effect of the F339 loss-of-function mutation in KCNQ1 that affects K V 7.1 channels is almost negligible. The gain of function of I Ks was more critical. The increase in outward current resulted in a DDR reduction that far outweighed the accompanying APD reduction. Thus, the gain-of-function mutations R231C and V241F resulted in a rate slowdown compatible with the clinically observed sinus bradycardia. However, it should be noted that the electrophysiological characterizations of both R231C and V241F were obtained in homozygous expression (Table 4) . Although no experimental data are available concerning the R231C and V241F mutations in heterozygous expression, we decided to include these simulations anyway to provide a lower limit of the beating rate that the model can achieve for these mutations.
The comparison between clinical findings and simulated effects of mutations on beating rate showed good overall behaviour of the model. Except for the I Ks F339 mutation, simulated effects on beating rate were in accordance with the reported clinical data (Fig. 6) . It should be noted that there is always a gap between clinical and simulated mutation effects, given the difference in the systems analysed: the heart rate is a macroscopic phenomenon, resulting from the overall SAN tissue behaviour and its interaction with the autonomic nervous system, whereas the beating rate predicted by the model considers only the microscopic single cell level. At this level, there is (for example) no hyperpolarizing effect of the surrounding atrium, which may increase I f and I Na and thus the functional effects of mutations in the associated genes. It should also be noted that carriers of the same mutation may show widely different phenotypes, even within the same family. This holds in particular for the SCN5A mutations; it is possible that only a minority of the affected family members show sinus node dysfunction. Finally, other factors, such as physical training level, can affect the difference in basal heart rate found between healthy subjects and mutation carriers.
As emphasized by Verkerk and Wilders (2015) for HCN4 mutations, although it can be readily extended to other ion channels, there are inconsistencies between clinical and experimental data. Many factors can underlie these inconsistencies: (i) data on current density can be misleading because heterologous systems (in vitro) can express different levels of the gene affected by the mutation with respect to the subject (in vivo) under investigation; (ii) experimental data can be incomplete and may strongly depend on the expression system and the experimental protocol employed; (iii) clinical data are often limited to a small number of patients, or even a single patient; (iv) the affected isoform is not the only one expressed in vivo; and (v) remodelling processes can occur in mutant carriers and affect their clinical phenotypes.
Physiological insights from simulations
Simulating I f and NCX blocks and autonomic stimulation provided insights into the model behaviour and shed light on underlying phenomena.
Lower levels of I f block and shifts of the steady-state activation curve were able to modulate pacemaking rate, mainly by varying DDR 100 . By contrast, MDP and APD 90 showed no changes (Figs. 7 and 8 ). These results suggest that I f exerts its capability to modulate beating rate during the DD phase. As previously shown for the rabbit SAN AP, controlling the steepness of early DD is an efficient way of determining beating rate: small changes in currents are able to substantially modify the slope of DD, and thus the overall duration of the AP. This is even more true in human SAN because the pacing rate is even more sensitive to changes in DD slope. As a result of the non-linear relationship between dV/dt and time (Zaza, 2016) , the same change in current is bound to produce larger changes in CL when basal CL is longer. Unlike the parent model, pacemaker activity does not cease when I f is fully blocked. Yet, the modulatory role of I f is as important as in the parent model.
NCX provided an important contribution to automaticity, both during DD and during the AP upstroke. The considerable reduction of its maximal activity relative to the parent model, consistent with the gene expression pattern reported by Chandler et al. (2009), allowed [Ca 2+ ] i to reach a value closer to experimental values. The NCX block showed two different effects: for low-to-moderate levels of block, the beating rate became faster than under control conditions, whereas for high-to-almost-full block, the automaticity stopped (Fig. 9) . The latter result is consistent with experiments showing an inhibitory effect of Na + replacement by Li + , thus abolishing NCX, on spontaneous beating in rabbit SAN cells (Bogdanov et al. 2001) . The unexpected effect of rate acceleration upon low-to-moderate block can be the result of a counterintuitive, although physiological, process: a lower maximal NCX activity results in a higher [Ca 2+ ] i during DD and, consequently, a more intense I NaCa . Nevertheless, the rate increase induced by I NaCa reduction is actually a prediction of our model, and experimental data (not available yet) are needed to confirm this prediction in human SAN cells.
Unlike I f modulation, NCX block affected several main features: DDR 100 , MDP, APD 90 and even APA underwent considerable changes (Fig. 9 ). Of note, both the absolute and relative amplitude of I f and I NaCa during DD were highly similar to those predicted by Verkerk et al. (2013) through numerical reconstruction.
It is worth noting that the 'calcium clock' was integrated in the parent model and it is also present in this human model but, as expected, the NCX current cannot effectively modulate the pacemaking rate. Based on the rabbit model simulations, the SERCA pump activity could be expected to modulate pacemaking rate. This was not the case in our model, in which changes in SERCA maximal activity had a negligible effect on rate. This leaves open the question about the actual relevance of the 'calcium clock' in human SAN.
The adopted calcium handling considered the presence of a subsarcolemmal space, which is also present in the rabbit SAN cell models of Kurata et al. (2002) , Maltsev and Lakatta (2009) and Severi et al. (2012) . Because T-tubules are poorly defined in SAN cells, this subsarcolemmal space is proposed as a 'fuzzy space' (Lederer et al. 1990 ). NCX1 and RyRs are co-located there, as reported by Lyashkov et al. (2007) , who used immunolabelling techniques and confocal imaging. Through further simulations, we tested the effect of a different cell arrangement of RyRs in the cell space. We progressively switched the SR release from the subspace to the cytosol until a 100% Ca 2+ release, targeted to the cytosol and sensitive to Ca i instead of Ca sub , was reached. The model did not show dramatic changes; in an SR release configuration fully targeted to cytosol, we only observed a minor change of pacemaking rate (+5.2%; from 74 to 78 beats min -1 ), as well as a minor increase in Ca i (Ca i,min from 84 to 99 nM, Ca i,max from 189 to 199 nM).
The only study to report experimental data on the administration of ACh and Iso in human SAN tissue was carried out by Drouin (1997) . However, the observed intrinsic pacemaking frequency was not coherent with clinical observations (30 beats min -1 in vitro vs. 70-112 beats min -1 in situ); it is therefore most probable that the effects of ACh and Iso were exacerbated. Furthermore, ACh and Iso targets are not electrophysiologically characterized in humans, and so we used experimental data from rabbit SAN. Thus, our simulations of ACh and Iso effects provide theoretical insights about the mechanisms underlying autonomic modulation that may require updates with respect to future data that become available from human tissue.
The administration of 10 nM ACh led to a reduction of the pacemaking rate as a result of the activation of I K,ACh together with changes to I f , SR uptake and I CaL . The ACh-induced reduction of I f and activation of I K,ACh appeared to be the major determinants of rate slowdown.
The overall pacing rate acceleration as a result of the administration of 1 μM Iso was the result of a balance between opposing contributors. An assessment of the role of each of the five targets (I f , I NaK , I CaL , I Ks and SR uptake) showed that both I f and I CaL changes led to a faster beating rate. However, the underlying mechanisms were different: I f worked on the early phase of DD, modifying DDR 100 (also shown in I f modulation caused by shifts in voltage dependence), whereas I CaL exerted its effect during late DD. I NaK showed an enhanced activity with Iso that decreased DDR and therefore counteracted the overall pacing rate acceleration.
An important test of the validity of the model was its ability to reproduce the clinical range of human heart rate. Our model was able to provide stable automaticity at ß40 beats min -1 upon administration of 25 nM of ACh, whereas the maximum rate (180 beats min -1 ) was obtained by enhancing the effects of Iso on its target parameters.
The overall message from model-based simulations of autonomic modulation of pacemaking is that I f plays an important role in rate regulation, as in rabbit. However, at least one other current (I K,ACh for ACh and I CaL for Iso administration) needs to be modulated to achieve pacemaking rate regulation in the full physiological range.
Limitations and future developments
One evident limitation of the present study is that there are insufficient experimental data available on human SAN electrophysiology to fully constrain the parameters of the model. It is therefore possible that some non-human-specific aspects of the parent (rabbit) model are still present. This could be the case for some aspects of the calcium handling, which could underlie the very high frequency of spontaneous calcium oscillations. The present model thus only represents one step forward in the quantitative description of human SAN electrophysiology. Further experiments carried out on human adult SAN cells, or perhaps even on human induced pluripotent stem J Physiol 595.7 cell-derived cardiomyocytes, will challenge the current model, providing confirmation and/or clarifying any changes that need to be made.
Specific limitations of the model include: the lack of intracellular sodium dynamics, the stop of pacemaking beating when [Ca 2+ ] o is set to a physiological in vivo value (1.15 mM; Severi et al. 2009 ) and the lack of a detailed description of local calcium releases.
Conclusions
In the present study, we present a human sinus node AP model based on electrophysiological data. The model is able to reproduce the experimentally observed AP morphology, calcium transient and CL prolongation upon I f block by 2 mM Cs + , as well as the effects of mutations responsible for cardiac ion channelopathies associated with sinus node dysfunction.
In addition to contributing to a better understanding of the events that occur on the cellular scale, the model could be a useful tool in the design of future experiments and the study (at a preliminary stage) of the effects of drugs that aim to modulate heart rate.
Appendix 1
Model parameters and equations
Cell compartments.
cell capacitance 
submembrane space volume Hyperpolarization-activated, 'funny current' (I f ). I NaCa = K NaCa · (x2 · k21 − x1 · k12) x1 + x2 + x3 + x4
RTonF + Nai K cni kf CQ = Ca 2+ association constant for calsequestrin I NaK,max = maximal Na + /K + pump current
Action potential features used to constrain model parameters
Experimental data on APA, MDP, CL, V max , APD 20 , APD 50 , APD 90 , DDR 100 and CL prolongation induced by Cs + of single isolated human SAN cells as reported by Verkerk et al. (2007b) were used to constrain model parameters.
Data on CL prolongation induced by Cs
+ are from only one cell. We arbitrarily adopted an SEM of 10% of the experimentally observed CL prolongation.
Calcium transient features used to constrain model parameters
Experimental data on diastolic [Ca 2+ ], systolic [Ca 2+ ], TD 20 , TD 50 and TD 90 of a single isolated human SAN cell as reported by Verkerk et al. (2013) were used to constrain model parameters.
Because the experimental data on the calcium transient are from only one cell, we arbitrarily set the SEM of each of the calcium transient features to 40% in our optimization procedure.
Cost function
In our optimization procedure, we minimized the overall cost function FCost, which was defined as:
in which Cost i denotes the individual contribution of feature i to the overall cost.
Cost i is described as (Fig. A1 We set weight i = 2 for MDP, CL and CL prolongation induced by Cs + , whereas weight i was set to 1 for all other features.
Search method and stop criterion
The initial values of the selected parameters were obtained from the parent (rabbit) model and then manually tuned to achieve beating rate and action potential morphology close to the experimental human data. Such initial values were then employed to perform the above-mentioned finer automatic optimization.
The minimization of the overall cost function FCost was based on the Nelder-Mead simplex method (Lagarias et al. 1998). The automatic optimization procedure stopped when FCost converged on a local minimum.
Parameter constraining
To determine whether the parameters are well constrained we followed the approach by Sarkar and Sobie (2010) . Accordingly, the extended Bayes theorem was exploited to define a range for parameters, for which a population of models is able to reproduce behaviour in agreement with experimental data. The parameter constraining is performed by increasing the number of features to satisfy: the higher the number of selected features, the lower the number of compatible parameter sets. In a similar way, we selected MDP, CL, APD 90 and DDR 100 from the available 13 extracted features, within the target range (i.e. mean ± SEM of experimental values) and obtained the ranges in Table A1 .
The collected values show an adequately constrained range for the optimized parameters. To achieve this result, we exploited a priori knowledge during the optimization procedure; accordingly, we avoided non-physiological values (negative conductances or values too far from data reported in literature), assigning high scores to their cost function.
The achievement of more than one parameter set that falls into experimental ranges could attest the robustness of the model, which is able to adequately compensate for parameter changes without adopting parameter values beyond the physiological range.
